Blood Substitutes and Oxygen Therapeutics: A Review.
Anesth Analg
; 132(1): 119-129, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-30925560
Despite the exhaustive search for an acceptable substitute to erythrocyte transfusion, neither chemical-based products such as perfluorocarbons nor hemoglobin-based oxygen carriers have succeeded in providing a reasonable alternative to allogeneic blood transfusion. However, there remain scenarios in which blood transfusion is not an option, due to patient's religious beliefs, inability to find adequately cross-matched erythrocytes, or in remote locations. In these situations, artificial oxygen carriers may provide a mortality benefit for patients with severe, life-threatening anemia. This article provides an up-to-date review of the history and development, clinical trials, new technology, and current standing of artificial oxygen carriers as an alternative to transfusion when blood is not an option.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxigênio
/
Substitutos Sanguíneos
/
Transfusão de Sangue
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article